title: The natural history of degenerative ataxia: a retrospective study in 466 patients.
abstract: The aim of the present study was (i) to compare disease progression and survival in different types of degenerative ataxia, and (ii) to identify variables that may modify the rate of disease progression. We included patients suffering from Friedreich's ataxia (FRDA, n = 83), early onset cerebellar ataxia (EOCA, n = 30), autosomal dominant cerebellar ataxia (ADCA) type I (ADCA-I, n = 273), ADCA-III (n = 13) and multiple system atrophy (MSA, n = 67). Molecular genetic testing allowed us to assign 202 ADCA-I patients to one of the following subgroups: spinocerebellar ataxia type I (SCAI, n = 36), SCA2 (n = 56) and SCA3 (n = 110). To assess disease progression we defined the following disease stages: stage 0 = no gait difficulties; stage 1 = disease onset, as defined by onset of gait difficulties; stage 2 = loss of independent gait; stage 3 = confinement to wheelchair; stage 4 = death. Disease progression was most rapid in MSA, intermediate in FRDA, ADCA-I and ADCA-III and slowest in EOCA. The rate of progression was similar in SCA1, SCA2 and SCA3. The CAG repeat length was a significant risk factor for faster progression in SCA2 and SCA3, but not in SCA1. In FRDA, the time until confinement to wheelchair was shorter in patients with earlier disease onset, suggesting that patients with long GAA repeats and early disease onset have a poor prognosis. Female gender increased the risk of becoming dependent on walking aids or a wheelchair, but it did not influence survival in FRDA, SCA3 and MSA. In SCA2, female gender was associated with shortened survival. In MSA, later age of onset increased the risk of rapid progression and death.
authors.affiliation: Department of Neurology, University of Tübingen, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Klockgether
authors.forename: R
authors.initials: R
authors.lastname: Lüdtke
authors.forename: B
authors.initials: B
authors.lastname: Kramer
authors.forename: M
authors.initials: M
authors.lastname: Abele
authors.forename: K
authors.initials: K
authors.lastname: Bürk
authors.forename: L
authors.initials: L
authors.lastname: Schöls
authors.forename: O
authors.initials: O
authors.lastname: Riess
authors.forename: F
authors.initials: F
authors.lastname: Laccone
authors.forename: S
authors.initials: S
authors.lastname: Boesch
authors.forename: I
authors.initials: I
authors.lastname: Lopes-Cendes
authors.forename: A
authors.initials: A
authors.lastname: Brice
authors.forename: R
authors.initials: R
authors.lastname: Inzelberg
authors.forename: N
authors.initials: N
authors.lastname: Zilber
authors.forename: J
authors.initials: J
authors.lastname: Dichgans
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000368:Aged; D002524:Cerebellar Ataxia / Q000235:genetics / Q000401:mortality / Q000503:physiopathology*; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005260:Female; D005621:Friedreich Ataxia / Q000235:genetics / Q000401:mortality / Q000503:physiopathology*; D005684:Gait; D006801:Humans; D008297:Male; D008875:Middle Aged; D019578:Multiple System Atrophy / Q000235:genetics / Q000401:mortality / Q000503:physiopathology*; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D012727:Sex Characteristics; D013132:Spinocerebellar Degenerations / Q000235:genetics / Q000401:mortality / Q000503:physiopathology*; D016019:Survival Analysis; D013997:Time Factors; D018911:Trinucleotide Repeats; D014910:Wheelchairs